0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

GNAL Mutations and Dystonia

Roberto Erro, MD1,2; Kailash P. Bhatia, MD, FRCP1; John Hardy, MD3,4
[+] Author Affiliations
1Sobell Department of Motor Neuroscience and Movement Disorders, University College London Institute of Neurology, London, England
2Dipartimento di Scienze Neurologiche e del Movimento, Università di Verona, Verona, Italy
3Department of Molecular Neuroscience, University College London Institute of Neurology, Queen Square, London, England
4Reta Lila Weston Institute, University College London Institute of Neurology, London, England
JAMA Neurol. 2014;71(8):1052-1053. doi:10.1001/jamaneurol.2014.1506.
Text Size: A A A
Published online

Extract

To the Editor We read with great interest the article by Kumar and colleagues1 published in JAMA Neurology. They screened 318 patients with different types of dystonia, mainly sporadic, from Germany, Serbia, and Japan for mutations in all 12 exons of GNAL and found 2 putative mutations (c.637G>A and c.1057G>A) in 2 sporadic cases with craniocervical dystonia and cervical dystonia, respectively. The prevalence estimate of GNAL cases according to their figure is 0.62%, which is much lower than originally reported.2 The initial discovery report by Fuchs et al2 reported GNAL mutations in 6 of 39 families screened (approximately 15%). However, in the subsequent study by Vemula et al,3 only 3 GNAL mutations were detected in 760 individuals with familial or sporadic primary dystonia (<0.5%). Furthermore, a number of groups have subsequently screened different cohorts of patients with dystonia for GNAL mutations, yielding conflicting prevalence estimates (Table).

Topics

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

August 1, 2014
Kishore R. Kumar, MBBS, FRACP; Kirill A. Martemyanov, PhD; Katja Lohmann, PhD
1Institute of Neurogenetics, University of Luebeck, Luebeck, Germany2Department of Neurogenetics, Kolling Institute of Medical Research, Royal North Shore Hospital and University of Sydney, Sydney, Australia
3Department of Neuroscience, The Scripps Research Institute, Jupiter, Florida
1Institute of Neurogenetics, University of Luebeck, Luebeck, Germany
JAMA Neurol. 2014;71(8):1053-1054. doi:10.1001/jamaneurol.2014.1509.
CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

360 Views
3 Citations
×

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Jobs
brightcove.createExperiences();